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Abstract
Background: Bovine tuberculosis (bTB) in wildlife species poses a threat to domestic livestock in many situations.
Control programs for bTB in livestock depend on testing and slaughtering the positive animals; however, the
currently available diagnostic tests often have poor specificity. In our previous study, we developed a specific and
sensitive enzyme linked immunosorbent assay (ELISA) for another mycobacterial disease – Johne’s disease, using
surface antigens of Mycobacterium avium ssp. paratuberculosis (MAP) extracted by briefly agitating the bacilli in 80%
ethanol solution. The ELISA test was named ethanol vortex ELISA (EVELISA). The objective of this study is to
examine whether EVELISA technique could be used to specifically detect anti-Mycobacterium bovis (M. bovis)
antibodies in the serum of M. bovis-infected farmed red deer (Cervus elaphus). We tested a total of 45 red deer
serum samples, divided in 3 groups – uninfected animals (n = 15), experimentally infected with M. bovis (n = 15)
and experimentally infected with MAP (n = 15).
Results: The presence of anti-M. bovis antibodies was tested using an ethanol extract of M. bovis. Without absorption
of anti-MAP cross reactive antibodies, it was found that 13 out of the 15 MAP-infected animals showed high antibody
binding. Using heat killed MAP as an absorbent of cross reactive antibodies, anti-M. bovis antibodies were detected in
86.7% of M. bovis-infected animals with minor false positive results caused by MAP infection.
Conclusions: The results from this study suggest that EVELISA may form a basis for a sensitive and specific test for the
diagnosis of bTB in farmed red deer.
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Background
Farming of red deer (Cervus elaphus) has been an emer-
ging alternative livestock industry mainly in New Zealand,
USA, China, Russia and Canada [1]. Being in continuous
contact with the livestock and the free-ranging wildlife,
farmed red deer populations are at increased risk to get
and spread infectious diseases. Bovine tuberculosis (bTB),
caused by Mycobacterium bovis (M. bovis), is a chronic in-
fectious disease of international zoonotic and economic
importance [2]. It is characterized by the formation of
granulomatous lesions with varying degrees of necrosis,
calcification and encapsulation [3-7]. bTB has been identi-
fied in a wide range of wildlife species, domestic animals
and humans [8,9]. Global economic loss due to bTB is es-
timated to be about US$ 3 billion annually [10]. Since
there are no effective treatments or vaccines for bTB,
rigorous testing and removal of diseased animals remains
the only control measure.
In contrast to the control programs for bTB in wildlife
species, bTB in farmed deer is primarily monitored by
skin testing and rarely by slaughter surveillance. One of
the major ante mortem tests for bTB is the tuberculin
skin test (TST) using purified protein derivatives (PPD)
of M. bovis [4,11]. In the US, there is requirement of a
negative skin test for interstate transport and it includes
a voluntary herd accreditation program [12]. However,
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the participation in such programs is very low due to in-
adequate handling facilities and need to recapture ani-
mals for testing 72 hours after the injection of PPD
[13,14]. Further, a recent study showed that interpret-
ation of TST could be confounded by infection of red deer
with environmental mycobacteria [15]. An interferon-γ re-
lease assay has also been evaluated for bTB diagnosis in
capture cervids, [16,17] but the test requires fresh blood
samples and also has not been validated for diagnosis of
bTB in free-ranging wildlife species [18]. Antibody-based
assays for detection of bTB have shown promising results
due to their flexibility and cost effectiveness. Prior studies
on the development of antibody based assays have used
cross-reactive preparations of M. bovis, such as a crude
cell sonicate [19] culture filtrate [20] PPD [21] and lipoar-
binomannan (LAM) [22]. Specific molecules like ESAT-6,
CFP10, MPB83 and MPB70 have also been used for detec-
tion of anti-M. bovis antibodies [23-25]. Recent studies
have demonstrated the advantages of using multiple anti-
gens (e.g. ESAT-6, CFP10 and MPB83) in multi-antigen
print immune-assay (MAPIA) [12,26], lateral flow rapid
test (RT) [18] or dual path platform (DPP) [27] assays.
Although these studies have shown promising results
in detecting antibodies against M. bovis, the presence
of anti-Mycobacterium avium ssp. paratuberculosis (MAP)
antibodies due to confounding factors like infection and/or
vaccination may cause interference in interpretation [28].
We have previously developed a novel enzyme-linked
immunosorbent assay (ELISA), called an ethanol vortex
ELISA (EVELISA) using surface antigens of MAP for de-
tecting anti-MAP antibodies in serum at early stages of
Johne’s disease (JD) [29-32]. The aim of the present
work was to assess the performance of EVELISA opti-
mized to diagnose bTB using serum samples from vari-
ous groups of red deer (Cervus elaphus) including animals
experimentally infected with M. bovis or MAP.
Methods
Samples
In order to evaluate the performance of EVELISA, a
total of 45 red deer sera were obtained from 3 different
studies in New Zealand. The first group (Uninfected)
consisted of 15 deer approximately 12 months old,
which were not challenged with either of M. bovis or
MAP. All the animals in this group were culture nega-
tive for M. bovis using lymph node samples and blood
samples taken one week prior to slaughter were all
serologically negative for MAP using an IgG1 ELISA
test (Paralisa™, Disease Research Laboratory (DRL),
Department of Immunology and Microbiology, Univer-
sity of Otago, Dunedin, NZ) [33]. The second group
(M. bovis infected) consisted of 15 deer approximately
12 months old, which had been experimentally chal-
lenged using 0.2 mL volume of 500 CFU of M. bovis
into the left tonsillar crypt of anesthetized deer [34].
M. bovis was isolated at slaughter from gross lesions or
pooled lymph node samples (head, thoracic or intes-
tinal lymph nodes) from all 15 deer 27 weeks after ex-
perimental challenge. All blood samples were tested
using an ELISA Tb test called EBT [35] and a com-
parative cervical tuberculin test (CCT) [36]. For the
CCT, intradermal injections of 0.1 mL of avian tuber-
culin (2500 IU; A) and bovine tuberculin (5000 IU; B)
were given at two closely clipped sites on the neck.
Skin thickness was measured before injection and
72 hours later. The CCT is considered positive if the
increase at site B is greater than or equal to site A;
and, negative if site A is greater than site B. All the an-
imals in the second group (M. bovis infected) were
tested positive by CCT. Serum samples of 11 out of
the 15 animals in this group were positive by ETB. Of
the 15 blood samples collected a week prior to slaugh-
ter, 7 samples were seropositive for MAP using the
Paralisa™ test. Finally, the third group (MAP infected)
consisted of 15 deer experimentally infected with MAP
as previously described [33]. All the samples in this
group were from animals sourced from a property with
no history of bTB or JD. MAP was isolated from all the
deer in this group by culture after 50 weeks post infec-
tion and 12 out of the 15 samples collected immedi-
ately before slaughter were seropositive using the
Paralisa™ test. Serum samples of 10 out of the 15 ani-
mals in this group were positive by ETB, showing high
false positive rate in MAP infected animals. Animal
use described in this study was approved by the AgRe-
search Invermay Ethics Committee (AEC11115).
EVELISA
A virulent strain of M. bovis (HC2005T), which was origin-
ally isolated from an M. bovis infected dairy cow, was cul-
tured in Middlebrook’s 7H9 medium (Becton Dickinson,
Cockeysville, MD) with addition of 0.05% Tween 80
(Fisher Scientific, Fair Lawn, NJ), 10% oleic acid-albumin-
dextrose-NaCl (Becton Dickinson, Microbiology Systems,
Franklin Lakes, NJ) at 37°C. For antigen preparation
M. bovis bacilli were harvested from stationary phase
cultures, and centrifuged at 2,600 × g for 10 minutes;
the pellet was then suspended in 80% ethanol and agi-
tated by vortex at room temperature for 2 min, and
centrifuged at 10,621 × g for 10 minutes to dislodge
surface antigens. Extracted M. bovis antigen was di-
luted in the ethanol solution and 50 μL of the solution
was immobilized on wells of a 96-well plate by evapor-
ation. MAP (K10 strain) was used for preabsorption
step in this study. The antigen-coated plate was incubated
with 150 μL of buffer B (10 mM phosphate buffered sa-
line, pH 7.0, containing 0.05 v/v% Tween 20 and 10 v/v%
SuperBlock [PIERCE Biotechnology, Rockford, IL]) at
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room temperature for 30 min. The plate was then
washed 4 times with 200 μL of PBST (10 mM phos-
phate buffered saline, pH 7.0, containing 0.05% Tween
20). Fifty μL of serum sample (with or without preab-
sorption of cross-reactive antibodies with heat-killed
MAP [K10 strain, 4 mg/mL] for 30 minutes) was then
inoculated and incubated at room temperature for one
hour [32]. After washing the wells four times with
200 μL of PBST, 50 μL of horseradish peroxidase
(HRP)-conjugated rabbit anti-deer IgG heavy and light
chains (1:1000 dilution; Kirkegaard & Perry Laborator-
ies, Inc. Gaithersburg, MD, diluted in buffer B) was
added in each well and incubated at room temperature
for one hour. After washing the wells four times with
200 μL of PBST, 100 μL of tetramethylbenzidine (TMB)
solution (Thermo Scientific, Rockford, IL) was used to de-
velop color reaction according to manufacturer’s instruc-
tion and optical density (OD) of the solution was
determined by a microplate reader (Model 680, BioRad,
Hercules, CA) at 450 nm for 10 min after terminating the
reaction by adding 100 μL of 2 M sulfuric acid.
Statistical analysis
All experiments were conducted in duplicate or tripli-
cate, and repeated at least twice. The test sensitivity was
determined by dividing the number of M. bovis culture-
test positive animals by the total number of M. bovis cul-
ture positive animals, with the result expressed as a
percentage. The test specificity was determined by
dividing the number of bTB free, test-negative animals
by the total number of bTB free animals, with the re-
sult expressed as a percentage. The cut-off value was
determined based on the two-graph receiver operating
characteristic analysis [37].
Results
The performance of EVELISA test to detect anti-M.
bovis antibodies in the sera of red deer was evaluated
and compared with or without the use of MAP as an ab-
sorbent for cross-reactive antibodies (Figure 1A-B).
Without pre-absorption of sera with MAP (Figure 1A),
14 out of 15 M. bovis positive samples (M. bovis-in-
fected) showed higher antibody binding levels than those
in any of uninfected samples (Uninfected). In the same
figure, 13 out of 15 samples in the third group (MAP-
infected) showed high antibody binding levels than
those in the uninfected samples, showing a high rate of
false positive reactions. In Figure 1B, antibody binding
was tested after absorbing cross-reactive antibodies
with heat-killed MAP bacilli. Antibody binding levels
in the MAP-infected groups were significantly reduced.
Two-graph receiver operating characteristic analysis
was used to calculate a cut-off value of 0.065 (Figure 2).
Anti- M. bovis antibodies were detected in 86.7% (13/15)
of M. bovis-infected animals. Out of the 15 animals in the
first group (Uninfected), 14 animals showed negative
reaction with the EVELISA. The most significant dif-
ference was that antibody binding levels in the third
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Figure 1 Diagnostic performance of EVELISA. Antibody binding was tested using 45 red deer serum samples, without (A) and with
(B) absorption of cross reactive antibodies against MAP. The samples were divided in 3 groups (Uninfected (n = 15); Infected with M. bovis (n = 15);
Infected with MAP (n = 15)). Each marker represents an average of duplicate measurements. To estimate tentative diagnostic sensitivity and specificity of
the EVELISA test, cut-off value of 0.065 (horizontal line) was used (B).
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group (n = 15, MAP infected) were reduced to the
same levels as the first group (Uninfected) and only
one sample in the MAP infected group showed anti-
body level higher than the cut-off value. We also tested
5 animals naturally infected with M. bovis and found
that all the animals had higher antibody binding than
the cut-off value (Mean ± standard deviation of absorb-
ance at 450 nm = 0.127 ± 0.103).
Discussion
Previous studies on developing ELISA for bTB in deer
have used PPD (bovine and avian), MPB70 [4,25,38], and
LAM [39,40]. Griffin et al. [35] have described the use
of bovine and avian PPD in comparative ELISA format
(B= > A) and suggested a sensitivity of 70% [35]. They
have also reported an ancillary blood test (BTB) which
is a composite test of both lymphocyte transformation
assay and the bovine PPD ELISA. The BTB showed a
high sensitivity of 94%; however, the test is a costly
assay compared to ELISA and is used as an ancillary
test to examine TST-reactors rather than for whole
herd testing. LAM has also been used as an antigen in
development of antibody based assays and to evaluate
antibody response kinetics on experimental inoculation
but it is cross reactive to antibody elicited by non-
tuberculous mycobacteria [39]. Waters et al. [40] suggested
the use of purified proteins to improve the specificity of
antibody based assays [40].
Recently, other serologic tests have been developed –
MAPIA, RT and dual-path-platform (DPP) VetTB assay –
using M. bovis-specific antigens such as MPB83, ESAT6
and CFP-10 antigens [18,26,41]. Sensitivities of MAPIA
and Cervid TB STAT-PAK were estimated to be 76.7%
and 72.5%, respectively, by using sera of cervids (C. ela-
phus) experimentally infected with M. bovis [42]. Buddle
et al. [28] compared the 2 lateral flow tests – CervidTB
STAT-PAK and DPP VetTB assay and reported specific-
ities of 83.8% and 91.4%, respectively [28]. Further, in a
following study, higher sensitivities of CervidTB STAT-
PAK (82%) and DPP VetTB (79%) were reported by
Waters et al. [12] by using sera of C. elaphus naturally
infected with M. bovis [12]. Boadella et al. [43] re-
ported a sensitivity of 51% and specificity of 96% for
fallow deer using bovine PPD ELISA. They also tested
DPP VetTB assay and depending on the cut-off value
selected, the sensitivity and specificity ranged from 62-
71% and 88-95%, respectively [43]. Although these
rapid tests show improved sensitivity and specificity,
preparation of the highly purified recombinant pro-
teins can be costly.
In this study, we used M. bovis antigens prepared sim-
ply by agitating the bacteria in an ethanol solution. Our
previous studies showed that ethanol extract of MAP
contains MAP-specific antigens and can be used to diag-
nose JD with high sensitivity [30,44]. We also showed
that absorption of cross reactive antibodies in serum
samples with Mycobacterium phlei improved specificity
of the EVELISA test for JD [32]. This is similar to the
observation in this study that specificity of EVELISA
test could be improved by absorption of cross reactive
antibodies by using environmental mycobacteria. After
absorption of cross reactive antibodies with MAP, anti-
M. bovis antibodies were detected in 86.7% of M. bovis-
infected animals with only a minor false positive result
in uninfected animals. Fourteen out of 15 samples
from animals in the group (MAP infected) were tested
negative by the EVELISA, indicating that a majority of
antibodies reacting with MAP were removed by the ab-
sorption. Thus, the results of this study suggest that
the EVELISA could diagnose bTB in MAP-infected red
deer with minimum false positive results caused by
antibodies reacting with MAP, encouraging further
studies to validate the test using a larger number of
samples obtained from red deer farms. In such studies,
it would be important to test the samples with other
M. bovis antigens (e.g. PPD, LAM and MPB70/83) to
directly compare the performance of EVELISA with
those of reported antigens.
Conclusion
The findings presented above indicate that EVELISA
could detect antibodies against M. bovis. However,
characterization of immunodominant antigens in the
ethanol extract and testing a larger number of sam-
ples for validation of the results are required. This
study suggests that EVELISA can form a basis for
Figure 2 Two-graph receiver operating characteristic analysis
of the EVELISA data for determination of a cut-off value. The
data shown in Figure 2 were plotted on a graph having cut-off
values on the X-axis and sensitivity (triangle)/specificity (circle) on
the Y-axis. The dotted line indicates the selected cut-off value (0.065).
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development of a sensitive and specific test for bTB in
deer.
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